Research
April 28, 2026
Research Day Showcases Translational Science’s Impact in Arkansas
The Translational Research Institute’s fifth annual Research Day highlighted the pivotal role of translational science in Arkansas, showcasing research presentations, panel discussions, and a poster session focused on scientific impact. A keynote presentation was delivered by Barry Coller, M.D., the David Rockefeller Professor of Medicine and head of the Allen and Frances Adler Laboratory of…
April 22, 2026
TRIumph Program Uses Communication to Connect Science to Community
Many people fear public speaking and rightly so. You’re on stage, out there in the spotlight, facing an audience filled with unknown faces and trying to connect through a story, while not misspeaking, boring the room to sleep, or freezing. For researchers talking to a lay audience, the challenge is magnified. The dread of public…
April 15, 2026
UAMS Showcase for Medical Discoveries Features Postdoctoral Fellows
The latest University of Arkansas for Medical Sciences (UAMS) Showcase of Medical Discoveries spotlighted the work of postdoctoral fellows.
March 24, 2026
The Team Behind the Trials
Good clinical trial research should be easy to start, run efficiently, and deliver health care impacts for patients. At the Clinical Trials Innovation Unit (CTIU), part of the Translational Research Institute at the University of Arkansas for Medical Sciences (UAMS), these ideas shape the team’s work. The unit is a comprehensive support system designed to…
March 23, 2026
UAMS Sees Record Participation for Student Research Day
The University of Arkansas for Medical Sciences (UAMS) experienced its biggest Student Research Day yet. More than 390 posters were submitted, with all five colleges and the Graduate School being represented between the main campus in Little Rock and the Northwest Regional campus in Fayetteville. Additionally, 40 students participated in the Three Minute Thesis (3MT)…
March 18, 2026
UAMS Researcher Receives $3.6 million NIH Grant to Study Diabetes and Cardiovascular Disease
LITTLE ROCK — Yunmeng Liu, Ph.D., an assistant professor in the College of Medicine Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS), has received a $3.6 million grant from the National Institutes of Health (NIH) to study diabetes and cardiovascular disease.
March 16, 2026
UAMS and Youth Researchers Help Expose Illegal ‘Mini-Cup’ and Toy-Shaped E-Cigarettes Promoted on Instagram
FAYETTEVILLE — A newly published study reveals that illegal e-cigarettes designed to resemble miniature boba tea cups, cola cans, and toy animals are being widely promoted on Instagram, often portraying young people using the products and marketing them in ways that may appeal to youth. The research, titled “#MiniCupVape E-Cigarettes Promoted on Instagram: A Youth…
February 26, 2026
Latest Showcase Celebrates Arkansas Children’s Research Institute
The first University of Arkansas for Medical Sciences (UAMS) Showcase of Medical Discoveries of 2026 broke new ground as the largest yet since its relaunch, with 35 research poster presentations.
February 25, 2026
UAMS Researcher Participates in $2 Million Project Examining DNA Damage and Cancer Mutations
LITTLE ROCK — Gunnar Boysen, Ph.D., associate professor in the University of Arkansas for Medical Sciences (UAMS) Fay W. Boozman College of Public Health Department of Environmental Health Sciences, is among a coalition of researchers assessing if damage in DNA happens on the same side that cancer mutations occur. The study aims to find out…
February 11, 2026
UAMS Research Shows Online Program Significantly Reduces Benzodiazepine Use in Adults
LITTLE ROCK — A new study involving University of Arkansas for Medical Sciences (UAMS) research scientists offers hope for patients who are seeking to reduce their dependence on benzodiazepines, powerful drugs prescribed to relieve anxiety and insomnia and reduce seizures.
Previous page Next page